Association of Soluble Endotoxin Receptor CD14 and Mortality Among Patients Undergoing Hemodialysis

American Journal of Kidney Diseases

Volumn 54, Issue 6, 2009, Pages 1062-1071

  Raj, Dominic S C ^a   Shah, Vallabh O ^b   Rambod, Mehdi ^c   Kovesdy, Csaba P ^d   Kalantar Zadeh, Kamyar ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Veteran Administrations Medical Center   (United States)

Author keywords

endotoxin; Hemodialysis; inflammation; mortality; nutritional status; soluble CD14

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; ENDOTOXIN; FERRITIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL DECISION MAKING; CYTOKINE RELEASE; DEATH; DISEASE MARKER; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMODIALYSIS; HUMAN; IRON BINDING CAPACITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PREDICTOR VARIABLE; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RISK FACTOR; SURVIVOR;

ADULT; AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 70449670853     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.06.028     Document Type: Article

References (41)

1. Szeto C.C., Kwan B.C., Chow K.M., et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 3 (2008) 431-436
2. Yamagami S., Adachi T., Sugimura T., et al. Detection of endotoxin antibody in long-term dialysis patients. Int J Artif Organs 13 (1990) 205-210
3. Lonnemann G., Behme T.C., Lenzner B., et al. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int 42 (1992) 61-68
4. Pereira B.J., Sundaram S., Barrett T.W., et al. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood. Clin Nephrol 46 (1996) 394-401
5. Nockher W.A., and Scherberich J.E. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: Evidence for chronic exposure to LPS. Kidney Int 48 (1995) 1469-1476
6. Goyert S.M., Ferrero E., Rettig W.J., et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239 (1988) 497-500
7. Pugin J., Heumann I.D., Tomasz A., et al. CD14 is a pattern recognition receptor. Immunity 1 (1994) 509-516
8. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
9. Agodoa L., Briggs J., Mitch W., et al. Nutrition in ESRD patients: Rationale and plan for an initiative. J Ren Nutr 9 (1999) 116-118
10. Kalantar-Zadeh K., and Kopple J.D. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38 (2001) 1343-1350
11. Wiedermann C.J., Kiechl S., Dunzendorfer S., et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the Bruneck Study. J Am Coll Cardiol 34 (1999) 1975-1981
12. Colman S., Bross R., Benner D., et al. The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) Study: Overview of the NIED Study and the role of dietitians. J Ren Nutr 15 (2005) 231-243
13. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 (2006) 202-210
14. Kalantar-Zadeh K., Brennan M.L., and Hazen S.L. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis 48 (2006) 59-68
15. Kalantar-Zadeh K., Kopple J.D., Kamranpour N., et al. HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int 72 (2007) 1149-1156
16. Mehrotra R., Kermah D., Fried L., et al. Chronic peritoneal dialysis in the United States: Declining utilization despite improving outcomes. J Am Soc Nephrol 18 (2007) 2781-2788
17. Beddhu S., Bruns F.J., Saul M., et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108 (2000) 609-613
18. Nelson E.E., Hong C.D., Pesce A.L., et al. Anthropometric norms for the dialysis population. Am J Kidney Dis 16 (1990) 32-37
19. Williams A.J., and McArley A. Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 9 (1999) 157-162
20. Kalantar-Zadeh K., Dunne E., Nixon K., et al. Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant 14 (1999) 169-175
21. Ridker P.M., Rifai N., Rose L., et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
22. Erbagci A.B., Tarakcioglu M., Aksoy M., et al. Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol 57 (2002) 197-204
23. Pecoits-Filho R., Barany P., Lindholm B., et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17 (2002) 1684-1688
24. Beutler B., and Cerami A. The biology of cachectin/TNF-A primary mediator of host response. Ann Rev Immunol 7 (1989) 625-655
25. Durrleman S., and Simon R. Flexible regression models with cubic splines. Stat Med 8 (1989) 551-561
26. Raetz C.R., and Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 71 (2002) 635-700
27. Heumann D., Gallay P., Barras C., et al. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol 148 (1992) 3505-3512
28. Wurfel M.M., Hailman E., and Wright S.D. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 181 (1995) 1743-1754
29. Kitchens R.L., Thompson P.A., Viriyakosol S., et al. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 108 (2001) 485-493
30. Pugin J., Schurer-Maly C.C., Leturcq D., et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A 90 (1993) 2744-2748
31. Fernandez-Real J.M., Broch M., Richart C., et al. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 88 (2003) 1780-1784
32. Raymond R.M. Skeletal muscle metabolism and insulin resistance during endotoxin shock in the dog. Am J Emerg Med 2 (1984) 45-59
33. Lang C.H., Frost R.A., Jefferson L.S., et al. Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I. Am J Physiol Endocrinol Metab 278 (2000) E1133-E1143
34. Anker S.D., Egerer K.R., Volk H.D., et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79 (1997) 1426-1430
35. Heine G.H., Ulrich C., Seibert E., et al. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 73 (2008) 622-629
36. Peeters A., Barendregt J.J., Willekens F., et al. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med 138 (2003) 24-32
37. Kalantar-Zadeh K., Block G., Humphreys M.H., et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003) 793-808
38. Beddhu S., Pappas L.M., Ramkumar N., et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14 (2003) 2366-2372
39. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 17 (2004) 229-232
40. Kalantar-Zadeh K., Kopple J.D., Kilpatrick R.D., et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 (2005) 489-500
41. Raj D.S., Carrero J.J., Shah V.O., et al. Soluble CD14 levels, interleukin-6 and mortality among prevalent hemodialysis patients. Am J Kidney Dis (2009) [in press]